-
Notifications
You must be signed in to change notification settings - Fork 0
Home
Here you will find details about
as well as how to run our three statistical models
- Cohort-level de novo recurrence
- Cohort-level compound heterozygous variant recurrence
- Individual-level compound heterozygosity
and details about
Our statistical models operate at the level of mutational targets, enabling cross-cohort analyses of rare disease patients which will be essential for improved disease gene discovery and diagnosis!
⭐ We highly encourage you to share summary statistics of your rare disease cohort for this purpose! ⭐
SN Kobren*, MA Moldovan*, R Reimers, D Traviglia, X Li, D Barnum, A Veit, J Willett, M Berselli, W Ronchetti, R Sherwood, J Krier, IS Kohane, Undiagnosed Diseases Network, SR Sunyaev (2024). "Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations." bioRxiv. doi: 10.1101/2024.02.13.580158.
Please message Shilpa Kobren or Mikhail Moldovan at {first name}_{last name} at hms.harvard.edu if you have questions or are interested in contributing to a meta-analysis!
RaMeDiES | Last updated: February 2024